Evidence map›Paper›PMID 37664409›Full record

ArticleArXiv2023

Enhancing cardiovascular risk prediction through AI-enabled calcium-omics.

Ammar Hoori, Sadeer Al-Kindi, Tao Hu, Yingnan Song, Hao Wu, Juhwan Lee, Nour Tashtish, Pingfu Fu, Robert Gilkeson, Sanjay Ra-Jagopalan and 1 more

Registry-linked trialOpen access · goldAbstract readPreprint
In one paragraph

Article in ArXiv, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04075162 (Community Benefit of No-charge Calcium Score Screening Program), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04075162 recruitingnot on this map

Community Benefit of No-charge Calcium Score Screening Program

Typeobservational_patient_registrySponsorUniversity Hospitals Cleveland Medical CenterRan2014 to 2030Enrolled77,000ConditionsCardiovascular Risk Factor
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 25 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ammar HooriDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Sadeer Al-KindiHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA.
Tao HuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Yingnan SongDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Hao WuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Juhwan LeeDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Nour TashtishHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA.
Pingfu FuDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.
Robert GilkesonHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA.
Sanjay Ra-JagopalanHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA.
David L WilsonDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

ACHIEVE P3 - CHDP50MD017351 · NIMHD · WAYNE STATE UNIVERSITY · PI DAILEY, RHONDA K · 2021 to 2025
$21.1M
Cardiovascular risk from comprehensive evaluation of the CT calcium score examR01HL165218 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI Sanjay Rajagopalan, DAVID Lynn WILSON · 2023 to 2026
$3.8M
Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CTR01HL167199 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI Sanjay Rajagopalan, DAVID Lynn WILSON · 2023 to 2026
$3.1M
Computer assisted coronary artery stent interventionsR01HL143484 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI BEZERRA, HIRAM, WILSON, DAVID LYNN · 2018 to 2021
$2.9M
System-independent quantitative cardiac CT perfusionR44HL156811 · NHLBI · BIOINVISION, INC. · PI ROY, DEBASHISH, WILSON, DAVID LYNN · 2021 to 2022
$2.0M
NHLBI NIH HHS R01 HL143484NHLBI NIH HHS R01 HL165218NHLBI NIH HHS R01 HL167199NHLBI NIH HHS R44 HL156811NIMHD NIH HHS P50 MD017351
6 · The paper itself

Abstract

Background: Coronary artery calcium (CAC) is a powerful predictor of major adverse cardiovascular events (MACE). Traditional Agatston score simply sums the calcium, albeit in a non-linear way, leaving room for improved calcification assessments that will more fully capture the extent of disease. Objective: To determine if AI methods using detailed calcification features (i.e., calcium-omics) can improve MACE prediction. Methods: We investigated additional features of calcification including assessment of mass, volume, density, spatial distribution, territory, etc. We used a Cox model with elastic-net regularization on 2457 CT calcium score (CTCS) enriched for MACE events obtained from a large no-cost CLARIFY program (ClinicalTrials.gov Identifier: NCT04075162). We employed sampling techniques to enhance model training. We also investigated Cox models with selected features to identify explainable high-risk characteristics. Results: Our proposed calcium-omics model with modified synthetic down sampling and up sampling gave C-index (80.5%/71.6%) and two-year AUC (82.4%/74.8%) for (80:20, training/testing), respectively (sampling was applied to the training set only). Results compared favorably to Agatston which gave C-index (71.3%/70.3%) and AUC (71.8%/68.8%), respectively. Among calcium-omics features, numbers of calcifications, LAD mass, and diffusivity (a measure of spatial distribution) were important determinants of increased risk, with dense calcification (>1000HU) associated with lower risk. The calcium-omics model reclassified 63% of MACE patients to the high risk group in a held-out test. The categorical net-reclassification index was NRI=0.153. Conclusions: AI analysis of coronary calcification can lead to improved results as compared to Agatston scoring. Our findings suggest the utility of calcium-omics in improved prediction of risk.

Identifiers

PMID37664409
PMCPMC10473778
OpenAlexW4386407683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.